Document is current
Any future updates will be listed below
-
Authors
Huang, Chenyang
Kong, Na
Xue, Pingping
Zhang, Hui
Ding, Lijun
Wang, Lingjuan
Zhou, Jianjun
Xing, Jun
Mei, Jie https://orcid.org/0000-0002-5182-5059
Sun, Haixiang
-
Funding
Funding for this research was provided by:
State Key Laboratory of Reproductive Medicine and Offspring Health (SKLRM-2022D2)
Research Project of Changzhou Medical Center of Nanjing Medical University, Key Program (CMCM202203)
Clinical Trials from the Affiliated Drum Tower Hospital, Medical School of Nanjing University (2022‐LCYJ‐ZD‐02)
Key Medical Research Project of Jiangsu Province Health Commission (K2023058)
- License Information
-
More Information
Article History
Received: 28 April 2025
Accepted: 15 September 2025
First Online: 9 October 2025
Declarations
:
: Title of the approved project: Clinical Study on the Treatment of Premature Ovarian Insufficiency with Umbilical Cord Mesenchymal Stem Cells. Name of the institutional approval committee: the ethics committee of Nanjing Drum Tower Hospital. Approval number: SC2018-001-05. Date of approval: October 27, 2020. All methods followed the relevant guidelines and regulations, strictly adhering to the Declaration of Helsinki. The patients provided written informed consent for participation in the study and/or the use of samples.
: Not applicable.
: The authors declare that they have no competing interests.
